Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity
申请人:Griffin James Douglas
公开号:US20110224194A1
公开(公告)日:2011-09-15
The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving deregulated FLT3 receptor tyrosine kinase activity, especially for the curative and/or prophylactic treatment of leukemias and myelodysplastic syndromes, and to a method of treating diseases involving deregulated FLT3 receptor tyrosine kinase activity.